Lunnon Metals Limited (ASX:LM8) December 2024 Quarterly Report
Lunnon Metals Limited reports advancements in gold exploration with a cash balance of $19.5 million as of December 31, 2024.
Category: Materials
Altamin Limited (ASX:AZI) Completes Acquisition of Vedra Interest
Altamin Limited confirms completion of its acquisition of Vedra, enhancing its ownership and strategic direction for the Gorno Project.
Infinity Lithium Corporation Limited (ASX:INF) Updates Mining Licence Application
Infinity Lithium (ASX:INF) shares an update on its Mining Licence Application and new funding strategies amidst project development changes.
Invictus Energy Ltd (ASX:IVZ) Quarterly Report Highlights
Invictus Energy Ltd (ASX:IVZ) reports key operational and corporate developments in its latest quarterly results.
Delta Lithium Limited (ASX:DLI) Announces Mt Ida Exploration Update
Delta Lithium has reported promising exploration results at its Mt Ida Gold Project, highlighting significant resource growth potential and development plans.
Poseidon Nickel Limited (ASX:POS) Reports Quarterly Highlights
Poseidon Nickel Limited (ASX:POS) reports on its proposed merger with Horizon Minerals and positive exploration outcomes.
Silver Mines Limited (ASX:SVL) Commences Drilling at Elsienora Project
Silver Mines Limited (ASX:SVL) begins drilling at the promising Elsienora Project, targeting substantial gold and silver resources.
International Graphite (ASX:IG6) Advances Graphite Projects
International Graphite (ASX:IG6) secures significant funding and advances projects, positioning itself as a leader in the graphite supply chain.
Sipa Resources Limited (ASX:SRI) Acquires 100% Ownership of Barbwire Terrace Project
Sipa Resources Limited (ASX:SRI) has secured full ownership of the Barbwire Terrace Project, advancing its exploration initiatives in Western Australia.
RLF AgTech Ltd (ASX:RLF) Announces Quarterly Updates and Debt Restructuring
RLF AgTech Ltd (ASX:RLF) announces quarterly results, significant debt restructuring, and product launches aimed at growth in Australia and China.